BiotechTube
Home/Response Pharmaceuticals/Paul Sweetnam, Ph.D.
PS

Paul Sweetnam, Ph.D.

Chief Scientific Officer & Co-Founder

Response Pharmaceuticals

Therapeutic Areas

Metabolic HealthWeight ManagementPsychiatry

Response Pharmaceuticals Pipeline

DrugIndicationPhase
RDX-002Antipsychotic-Induced Weight Gain (AIWG)Phase 1b

Leadership Team at Response Pharmaceuticals

EK
Eric Keller, J.D.
Chief Executive Officer, Founder & Chairman
WS
William Sasiela, Ph.D.
Chief Medical Officer
CM
Craig M. Audet, Ph.D.
Chief Regulatory Officer
View full Response Pharmaceuticals profile